Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Salpingo-oophorectomy 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1High-Throughput Nucleotide Sequencing 1Genotype 1Genetic Testing 1Genetic Counseling 1Counseling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Breast and Ovarian Cancer Syndrome × Genotype × 1 year × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡